West Pharmaceutical Services, Inc. Stock
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 235.46 USD | +1.89% |
|
-4.23% | -14.42% |
| Mar. 12 | John Chevedden Submits Shareholder Proposal to West Pharmaceutical | CI |
| Mar. 12 | West Pharmaceutical Receives Shareholder Proposal from John Chevedden | CI |
| Capitalization | 16.64B 14.55B 13.14B 12.57B 22.87B 1,539B 23.77B 157B 62.22B 735B 62.45B 61.13B 2,656B | P/E ratio 2026 * |
28.9x | P/E ratio 2027 * | 25.9x |
|---|---|---|---|---|---|
| Enterprise value | 15.76B 13.77B 12.44B 11.9B 21.65B 1,457B 22.5B 149B 58.91B 696B 59.13B 57.88B 2,515B | EV / Sales 2026 * |
4.85x | EV / Sales 2027 * | 4.49x |
| Free-Float |
95.72% | Yield 2026 * |
0.38% | Yield 2027 * | 0.41% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | +1.89% | ||
| 1 week | -4.23% | ||
| Current month | -7.42% | ||
| 1 month | -6.00% | ||
| 3 months | -13.39% | ||
| 6 months | -8.57% | ||
| Current year | -14.42% |
| 1 week | 228.4 |  | 249.16 |
| 1 month | 228.4 | | 254.6 |
| Current year | 223.83 | | 291.38 |
| 1 year | 187.43 | | 322.34 |
| 3 years | 187.43 | | 415.73 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 63.36 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 2015-04-23 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Quintin Lai
IRC | Investor Relations Contact | 59 | 2016-01-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Hofmann
BRD | Director/Board Member | 74 | 2007-10-15 |
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -3.15% | 1.02% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.89% | -4.23% | +5.24% | -26.70% | 16.64B | |
| -0.10% | -1.40% | -16.83% | +10.02% | 188B | |
| -0.27% | -4.14% | -5.62% | +11.75% | 112B | |
| -0.77% | -2.37% | +36.69% | +135.86% | 68.6B | |
| +0.22% | -1.33% | +61.47% | +94.91% | 58.6B | |
| -0.17% | -4.64% | -28.47% | -31.13% | 45.45B | |
| +0.95% | -5.41% | - | - | 33.33B | |
| -1.56% | -5.67% | -6.19% | -41.95% | 25.12B | |
| +1.05% | -6.92% | -3.54% | +20.14% | 20.83B | |
| +1.32% | +4.86% | -23.90% | +15.47% | 18.94B | |
| Average | +0.60% | -4.55% | +2.09% | +20.93% | 58.76B | |
| Weighted average by Cap. | +0.62% | -3.97% | +0.79% | +28.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.25B 2.84B 2.57B 2.46B 4.47B 301B 4.64B 30.66B 12.15B 144B 12.19B 11.94B 519B | 3.45B 3.02B 2.72B 2.61B 4.74B 319B 4.93B 32.55B 12.9B 152B 12.95B 12.67B 551B |
| Net income | 579M 506M 457M 437M 796M 53.56B 827M 5.46B 2.17B 25.59B 2.17B 2.13B 92.43B | 647M 566M 511M 489M 889M 59.84B 924M 6.1B 2.42B 28.59B 2.43B 2.38B 103B |
| Net Debt | -887M -775M -700M -670M -1.22B -82.04B -1.27B -8.37B -3.32B -39.2B -3.33B -3.26B -142B | -1.16B -1.02B -919M -879M -1.6B -108B -1.66B -10.98B -4.35B -51.42B -4.37B -4.27B -186B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-13 | 235.46 $ | +1.89% | 766,379 |
| 26-03-12 | 231.09 $ | -3.01% | 913,666 |
| 26-03-11 | 238.25 $ | +1.89% | 726,598 |
| 26-03-10 | 233.83 $ | -5.74% | 1,411,368 |
| 26-03-09 | 248.06 $ | +0.89% | 665,934 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
